Loxo Oncology (LOXO) Reports Q3 Loss of $0.82/Share
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Loxo Oncology (NASDAQ: LOXO) reported Q3 EPS of ($0.82), versus ($0.53) reported last year.
For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Comtech Telecom (CMTL) Tops Q1 EPS by 5c
- United Natural Foods (UNFI) Misses Q1 EPS by 4c, Reaffirms FY Guiance
- Ollie's Bargain Outlet (OLLI) Tops Q3 EPS by 3c, Offers FY Guidance
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!